key: cord-0963189-dqlfkzuu authors: Flaatten, Hans; Beil, Michael; Guidet, Bertrand title: Prognostication in elderly ICU patients: “mission impossible?” date: 2020-08-14 journal: British journal of anaesthesia DOI: 10.1016/j.bja.2020.08.005 sha: df98227465f95a42a6ede7209775715aa84366e3 doc_id: 963189 cord_uid: dqlfkzuu nan guidelines on the internet, 1, 2, 3, 4, 5 many with no firm connection to health authorities and usually reflecting only the view of an organization or individual authors and scientists. Te UK is one of the few countries with a national guideline for ICU pandemic triage is from the National Institute for Health And Care Excellence (NICE) 6 . Probably for the first time, frailty assessment was used at a national level to be the most important criterion for ICU triage. For those ≥ 65 yr old the Clinical Frailty Scale (CFS) was advocated as a tool in a holistic assessment of patients, but not for those < 65 yr. It is important to emphasize that a CFS ≥ 5, which was chosen as a threshold, was not absolute, and critical care could still be provided if it was considered appropriate. These triage guidelines were never intended to be an individual prognostic tool, but rather to identify groups of patients most likely to profit from intensive care in a situation where demand was higher than available resources. The alternative could be a chaotic process, with patients prioritized using a "first come first served" 7 approach, and triage criteria might be implemented locally as in fact happened in many hospitals during the initial COVID-19 pandemic surge in Europe 8 . It is important to use robust criteria for pandemic triage, and not surprisingly frailty was chosen above other criteria such as age alone, comorbidity or even severity of disease. In the last five years, a large body of evidence has been published on using frailty in prognostication for elderly ICU patients 9 . In Europe two large prospective studies in very old ICU patients recorded frailty prior to admission using the CFS 10, 11 . Both studies confirmed that frailty was J o u r n a l P r e -p r o o f one of the most important explanatory variables for outcome, including survival, in particular beyond ICU discharge. The study by Guidet and colleagues 11 confirmed the principal role of the CFS as a comprehensive descriptor of a patient's resilience since neither comorbidity, cognition or activities of daily living offered additional discriminating power to the analysis. In a pandemic this may be a desired feature of a tool used for triage, especially if it simplifies the process. The information needed to perform the CFS can also be retrieved reliably in retrospect 12 or be retrieved from medical records. In this issue of British Journal of Anaesthesia a study by Darvall and colleagues 13 from Australia and New Zealand challenges the part of the NICE triage guidelines that advises using CFS ≥ 5 as indicative of sufficient frailty, and hence patients are given less priority for intensive care admission. The authors use a comparative cohort of adult ICU patients ≥ 65 yr admitted with pneumonia. In their database CFS was scored at admission (but was not mandatory), and they found that only the two highest scores, CFS 7 and 8, were significantly associated with mortality. They concluded that a NICE threshold of CFS ≥ 5 is too low and should not be used. How solid is this conclusion? There are several important differences between their study group and COVID-19 patients treated for acute respiratory failure. First, it is far from evident that non-COVID-19 pneumonia is similar to the pulmonary failure seen during the present pandemic 14, 14a . Both their ICU and 30-day mortality in frail patients (12% and 21%, respectively) are much lower than mortality reported in patients with COVID-19 respiratory failure 15, 16, 17 . Also, the reported mortality in ventilator treated patients is very low indicating differences in population and probably also in process of care. The COVID-19 lung is probably very different from that in patients with pneumonia 18 , where outside the seasonal flu most have a bacterial origin. Since the present study cannot differentiate bacterial and viral pneumonia, this adds to the differences between this cohort and a cohort of COVID-19 patients. Second, the number of patients given noninvasive ventilation (NIV) in their cohort was very high, and the ratio of patients given mechanical ventilation (MV) to NIV was 1.1, while in an UK cohort of COVID-19 ICU patients this ratio was 2.8, 19 revealing large differences in respiratory management. Third, there also seems to be a large difference between their cohort and COVID-19 patients in the distribution of frailty. In the study by Darvall and colleagues 13 a cohort 1852 patients (33%) had CFS ≥5, while in a recent study in hospitalised patients from the UK and Italy 773 (49.4%) had CFS ≥ 5, indicating a very high CFS even in hospitalised patients 20 . Taken together, the information from their cohort does J o u r n a l P r e -p r o o f not seem to justify their conclusion not to use a particular CFS threshold for COVID-19related guidelines. As physicians, we would like to see triage criteria based on firm evidence about outcomes. However, this has proven difficult. The main challenge is the fact that in clinical work we deal with individuals and not groups. In individual patients, outcome is usually binary: survival or death. This is in contrast with group statistics where we can use probabilities of a specific outcome found in a fraction of that group. Thus, in the real word, ICU physicians do not use prognostic scores in isolation for their individual prognostications, but add a lot of other information about the patient before a decision is made. In particular dynamic information incorporating longitudinal data rather than a single static assessment should be used as suggested in the study by Darvall and colleagues. We acknowledge that this "normal" approach can be a problem in the late phase of an pandemic surge, where ICU capacity is far less than demand. Triage in such circumstances may have to use group level information, and if possible should combine two or more robust indicators available at admission. As such, the CFS, at least in the elderly cohort, seems to be a good choice, particularly when used with other information. Whether a CSF of 5 or 6 should be used will depend on available information, ideally derived from patients in the current pandemic and the urge for triage. This is why it is of vital importance to start prospective studies on patient outcomes at the earliest opportunity when a pandemic develops. The WHO initiative prior to this pandemic with a request to perform clinical studies on pandemic management 21 is a good example on how we should act in the future. HF drafted the first manuscript. BG and MB contributed to further discussion and refinement of the final manuscript. All authors are active collaborators in the Very old Intensive care Patients (VIP) project. Should we deny ICU admission to the elderly? Ethical considerations in times of COVID-19 Prioritisation of ICU treatments for critically ill patients in a COVID-19 pandemic with scarce resources COVID-19: Use of the Clinical Frailty Scale for critical care decisions Adult ICU Triage During the Coronavirus Disease 2019 Pandemic: Who Will Live and Who Will Die? Recommendations to Improve Survival Triage of Scarce Critical Care Resources in COVID-19 An Implementation Guide for Regional Allocation: An Expert Panel Report of the Task Force for Mass Critical Care and the American College of Chest Physicians COVID-19 rapid guidelines: Critical Care The good, the bad and the ugly: pandemic priority decisions and triage Will COVID-19 mark the end of an egalitarian National health service? MS Focus on the frail and elderly: who should have a trial of ICU treatment? The impact of frailty on ICU and 30-day mortality and the level of care in very elderly patients The contribution of frailty, cognition, activity of daily life and comorbidities on outcome in acutely admitted patients over 80 years in European ICUs: the VIP2 study Retrospective frailty determination in critical illness from a review of the intensive care unit clinical record Frailty and outcomes from pneumonia in critical illness: a population based cohort study BJA 2020 in press COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted? The Lancet Using applied lung physiology to understand COVID-19 patterns Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. The Lancet. Respiratory Medicine Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review COVID-19 report The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study. The Lancet